An epigenetic study of HCC also confirmed ESR1 as a tumor suppressor gene, with up to 83% of HCC patient tumors demonstrating ESR1 promoter hypermethylation (5) and predicting tumor progression (17). The gene discussed is ENSG00000279284; the disease is neoplasm.